Delivery Order SPE2DB20D2104-SPE2DB25FMFQW

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.15 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,079.04 firm fixed price delivery order is for 4566327881 ! NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product, with a completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,279.43 fixed-price delivery order contract is for the supply of NEXLETOL 180 MG Tablets and has a period of performance through January 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,262.86 issued by the Defense Logistics Agency (DLA). The contract is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price contract type. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,675.84 Firm Fixed Price delivery order is for the supply of NEXLETOL 180 MG TABLET, a prescription medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,846.10 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 29, 2023. The award is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.46, is a delivery order without any set-aside designation, indicating open competition. It covers the supply of NEXLETOL 180 MG TABLET to support military healthcare programs. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.51 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is for the delivery of NEXLETOL 180 MG TABLET UU 30S. The contract, valued at $3,256.13, is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical, a defense agency. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. The contract is not designated with a set-aside...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,892.62, is for the delivery of a pharmaceutical product, specifically NEXLETOL 180 MG TABLET, and is classified as a Firm Fixed Price Delivery Order. The award is not designated as a set-aside contract. This contract is associated with a larger Indefinite Delivery Contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFQW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,998.80 firm-fixed-price delivery order is for NEXLETOL 180 MG TABLET, a pharmaceutical product. The contract has a completion date of January 8, 2025.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/21/25, 10:27 AM